Lung Association Research Builds a Healthier Future

WALTHAM, MA (October 15, 2012)

Research Awards NationwideIt’s been said that “The best way to predict the future is to invent it.” The medical research supported by the American Lung Association does just that, by applying the most inventive and inquisitive medical minds to make a world free of lung disease a reality for future generations.

The American Lung Association Nationwide Research Program released its Research Awards Nationwide 2012-2013 report that highlights research supported by the Lung Association through its Asthma Clinical Research Centers (ACRC) and its Awards and Grants Program. This high quality research is funded with the goal of discovering effective prevention and treatment strategies as well as cures for lung disease.

Lung disease is now the third leading cause of death in the United States, responsible for one in six deaths. Almost 34 million people in the nation have chronic lung diseases, and alarmingly, more than seven million are children, burdened with asthma.  Lung cancer is the leading cause of death among all cancers for both men and women.  And nearly 13 million Americans have been diagnosed with Chronic obstructive pulmonary disease (COPD), while an equal number may also have COPD, but have not yet been diagnosed. 

Scientific research is clearly the front-line weapon in eliminating the terrible toll of lung disease on our families and loved ones. In 2012-2013, the Lung Association is providing more than $5 million to support approximately 90 lung disease research projects.  Previous medical advances made possible by the Lung Association’s research contributions have shed new light on a multitude of devastating lung diseases. 

One of the most problematic challenges clinician's face in the management of asthma is when a person is resistant to therapeutic effects of corticosteroid drugs, ordinarily the mainstay of treatment. As a result of the American Lung Association Biomedical Research Grant, Dr. Omar Tliba’s research has shown how a key molecule of the inflammatory process may play a role in this resistance and, most importantly, has suggested that the resistance to corticosteroid treatment in asthma may be reversed by vitamin D.

You can help researchers like Dr. Tliba and many others build a future where lung disease is a distant memory. Your tax-deductible donation to the American Lung Association can help continue to fund this lifesaving research.

# # #